We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$16.8M
Cap. Flow
+$19.2M
Cap. Flow %
11.58%
Top 10 Hldgs %
22.19%
Holding
254
New
38
Increased
43
Reduced
118
Closed
26

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$3.61M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$3.1M
3
AXSM icon
Axsome Therapeutics
AXSM
+$2.73M
4
PFE icon
Pfizer
PFE
+$2.64M
5
TRML
Tourmaline Bio
TRML
+$2.15M

Top Sells

Rank Stock Value
1
IMGN
Immunogen Inc
IMGN
+$3.78M
2
WBA
Walgreens Boots Alliance
WBA
+$3.13M
3
ABVX
Abivax
ABVX
+$2.86M
4
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$2.8M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 61.45%
2 Real Estate 11.2%
3 Financials 4.6%
4 Industrials 3.92%
5 Technology 2.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLE
226
DELISTED
BlackRock Municipal Income Trust II
BLE
– –
-5,700
Closed -$60.9K
DPRO
227
Draganfly
DPRO
$157M
– –
-20,000
Closed -$240K
ECH icon
228
iShares MSCI Chile ETF
ECH
$1.01B
– –
-662
Closed -$18.7K
EIM
229
Eaton Vance Municipal Bond Fund
EIM
$502M
– –
-5,000
Closed -$50.6K
HLX icon
230
Helix Energy Solutions
HLX
$1.41B
– –
-50,000
Closed -$514K
IRTC icon
231
iRhythm Holdings
IRTC
$3.64B
– –
-5,000
Closed -$535K
IRWD icon
232
Ironwood Pharmaceuticals
IRWD
$650M
– –
-245,000
Closed -$2.8M
MBLY icon
233
Mobileye
MBLY
$7.55B
– –
-20,000
Closed -$866K
MHD icon
234
BlackRock MuniHoldings Fund
MHD
$615M
– –
-5,150
Closed -$61.3K
MQY icon
235
BlackRock MuniYield Quality Fund
MQY
$830M
– –
-5,100
Closed -$62.2K
MUC icon
236
BlackRock MuniHoldings California Quality Fund
MUC
$1.02B
– –
-5,500
Closed -$61.2K
MUJ icon
237
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$651M
– –
-5,350
Closed -$61K
NDMO icon
238
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$625M
– –
-5,000
Closed -$49.5K
NMCO icon
239
Nuveen Municipal Credit Opportunities Fund
NMCO
$599M
– –
-5,000
Closed -$49.9K
NOTE
240
DELISTED
FiscalNote
NOTE
– –
-4,167
Closed -$57K
OMCL icon
241
Omnicell
OMCL
$2.07B
– –
-20,000
Closed -$753K
PMM
242
Franklin Managed Municipal Income Trust
PMM
$281M
– –
-8,125
Closed -$49.4K
VSTM icon
243
Verastem
VSTM
$534M
– –
-150,000
Closed -$1.22M
VTRS icon
244
Viatris
VTRS
$20.3B
– –
-35,000
Closed -$379K
WBA
245
DELISTED
Walgreens Boots Alliance
WBA
– –
-120,000
Closed -$3.13M
MUI
246
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
– –
-5,200
Closed -$60.5K
CBAY
247
DELISTED
Cymabay Therapeutics
CBAY
– –
-10,000
Closed -$236K
KRTX
248
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-3,500
Closed -$1.11M
IMGN
249
DELISTED
Immunogen Inc
IMGN
– –
-127,500
Closed -$3.78M
6 7 8 9
10

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, AlphaCentric Advisors held 254 positions worth $166M, up 11% from $149M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AlphaCentric Advisors deployed $19.2M of net new capital in Q1 2024, opening 38 new positions and adding to 43 existing holdings. Its largest new stake was United Therapeutics: 16,000 shares worth $3.68M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 59% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was Invesco NASDAQ 100 ETF, an estimated $1.72M trimmed.

  • AlphaCentric Advisors's largest Q1 2024 buy was United Therapeutics: 16,000 shares worth $3.68M.
  • AlphaCentric Advisors added most to Inari Medical, Inc. Common Stock in Q1 2024, an estimated $3.1M increase.
  • AlphaCentric Advisors's biggest Q1 2024 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $1.72M.
  • AlphaCentric Advisors fully exited Immunogen Inc in Q1 2024, selling an estimated $3.78M.
  • AlphaCentric Advisors's ten largest holdings make up 22% of its $166M portfolio in Q1 2024.
  • AlphaCentric Advisors opened 38 new positions and closed 26 in Q1 2024.
  • AlphaCentric Advisors's portfolio value rose 11% quarter-over-quarter to $166M.

Based on AlphaCentric Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.